These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3765655)

  • 1. Biotransformation of oxaprotiline: isolation and identification of metabolites in urine of rat and dog.
    Dieterle W; Faigle JW; Kriemler HP; Winkler T
    Xenobiotica; 1986 Aug; 16(8):743-52. PubMed ID: 3765655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic fate of [14C]oxaprotiline.HCl in man. II. Isolation and identification of metabolites.
    Dieterle W; Faigle JW; Kriemler HP; Winkler T
    Xenobiotica; 1984 Apr; 14(4):311-9. PubMed ID: 6464501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic fate of 14C-oxaprotiline X HCl in man. III. Stereospecific disposition.
    Dieterle W; Faigle JW; Küng W; Theobald W
    Biopharm Drug Dispos; 1984; 5(4):377-86. PubMed ID: 6525444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic fate of [14C]oxaprotiline.HCl in man. I. Disposition and preliminary pharmacokinetics.
    Dieterle W; Faigle JW; Imhof P; Sulc M; Wagner J
    Xenobiotica; 1984 Apr; 14(4):303-10. PubMed ID: 6464500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and identification of hydroxylated maprotiline metabolites.
    Breyer-Pfaff U; Kroeker M; Winkler T; Kriemler P
    Xenobiotica; 1985 Jan; 15(1):57-66. PubMed ID: 3984384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple inverse isotope dilution assay for the stereospecific quantitative determination of R(-) and S(+)-oxaprotiline in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1982 Jun; 242(2):289-97. PubMed ID: 6749873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs.
    Hoffmann KJ
    Drug Metab Dispos; 1986; 14(3):341-8. PubMed ID: 2872036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of nimodipine in rat, dog, and monkey.
    Scherling D; Bühner K; Krause HP; Karl W; Wünsche C
    Arzneimittelforschung; 1991 Apr; 41(4):392-8. PubMed ID: 1859512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which hydroxy? Evidence for species differences in the regioselectivity of glucuronidation in rat, dog, and human in vitro systems and dog in vivo.
    Martin IJ; Lewis RJ; Bernstein MA; Beattie IG; Martin CA; Riley RJ; Springthorpe B
    Drug Metab Dispos; 2006 Sep; 34(9):1502-7. PubMed ID: 16763016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of an anxiolytic imidazobenzodiazepine by the dog.
    Kolis SJ; Postma EJ; Williams TH; Sasso GJ; Schwartz MA
    Drug Metab Dispos; 1983; 11(4):324-8. PubMed ID: 6137338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary metabolites of semotiadil fumarate in the rat.
    Nakaoka M; Katoh K; Hakusui H
    Xenobiotica; 1995 Aug; 25(8):847-55. PubMed ID: 8779225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of nifedipine in rat and dog.
    Scherling D; Karl W; Radtke M; Ahr HJ; Siefert HM
    Arzneimittelforschung; 1992 Nov; 42(11):1292-300. PubMed ID: 1492841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites.
    Lundström J; Högberg T; Gosztonyi T; de Paulis T
    Arzneimittelforschung; 1981; 31(3):486-94. PubMed ID: 6452883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ibopamine metabolites in rat and dog urine.
    Kuo GY; Hwang BY; Lynn RK
    Drug Metab Dispos; 1988; 16(6):793-8. PubMed ID: 2907455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the metabolic pathways of alprenolol in man and the dog using stable isotopes.
    Hoffmann KJ; Arfwidsson A; Borg KO; Skånberg I
    Biomed Mass Spectrom; 1978 Nov; 5(11):634-40. PubMed ID: 749958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from laboratory animals.
    Pfadenhauer EH; Bankert CS; Jensen J; Jones CE; Jenkins EE; McCloskey JA
    Drug Metab Dispos; 1984; 12(3):280-4. PubMed ID: 6145553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.